Local expression of IL-18 in the temporal artery does not correlate with clinical manifestations of giant cell arteritis

Neuro-Ophthalmology

Volumn 32, Issue 1, 2008, Pages 3-6

  Nabili, Shahriar ^a   Bhatt, Priya ^a   Roberts, Fiana ^b   Gracie, Alastair ^b   McFadzean, Robert ^a  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Giant cell arteritis; Interleukin 18

Indexed keywords

C REACTIVE PROTEIN; CD68 ANTIGEN; COMPLEMENT COMPONENT C3B RECEPTOR; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 18;

ADULT; AGED; ANOREXIA; AORTA ARCH SYNDROME; ARTICLE; BLOOD VESSEL BIOPSY; CENTRAL RETINA ARTERY OCCLUSION; CLAUDICATION; CLINICAL ARTICLE; CLINICAL FEATURE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GIANT CELL ARTERITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALAISE; MALE; MYALGIA; OPTIC NERVE DISEASE; PROTEIN EXPRESSION; RHEUMATIC POLYMYALGIA; STROKE; TEMPORAL ARTERY;

EID: 39049102859     PISSN: 01658107     EISSN: 1744506X     Source Type: Journal    
DOI: 10.1080/01658100701818172     Document Type: Article

References (22)

1. Huston KA, et al. Temporal arteritis: A 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978;88(2):162-167.
2. Brack A, et al. Giant cell vasculitis is a T cell-dependent disease. Mol Med. 1997;3(8):530-543.
3. Weyand CM, Bartley, GB. Giant cell arteritis: New concepts in pathogenesis and implications for management. Am J Ophthalmol. 1997;123(3):392-395.
4. Weyand CM, et al. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum. 1997;40(1):19-26.
5. McInnes IB, et al. Interleukin 18: A pleiotropic participant in chronic inflammation. Immunol Today. 2000;21(7):312-315.
6. Okamura HT,H, Kashiwamura S, Yoshimoto T, Nakanishi K. Interleukin-18: A novel cytokine that augments both innate and acquired immunity. Adv Immunol. 1998;70:281-312.
7. Gracie JA, Robertson SE, McInnes IB. Interleukin-18. J Leukoc Biol. 2003;73(2):213-224.
8. Nordborg E, Nordborg C. Giant cell arteritis: Strategies in diagnosis and treatment. Curr Opin Rheumatol. 2004;16(1):25-30.
9. Gonzalez-Gay MA, The diagnosis and management of patients with giant cell arteritis. J Rheumatol. 2005;32(7):1186-1188.
10. Bongartz T,. Matteso EL. Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol. 2006;18(1):10-17.
11. Font C, C.M., Coll-Vinent B. Clinical features in patients with permanent visual loss due to biopsy-proven giant cell arteritis. Br J Rheumatol. 1997;36:251-254.
12. Evans JM, B.K. Hunder GG. Persistent giant cell arteritis despite corticosteroid treatment. Mayo Clin Proc, 1994;69:1060-1061.
13. Pease JE. Asthma, allergy and chemokines. Curr Drug Targets. 2006;7(1):3-12.
14. Romagnani P. From basic science to clinical practice: Use of cytokines and chemokines as therapeutic targets in renal diseases. J Nephrol. 2005;18(3):229-233.
15. Szekanecz Z, et al. Chemokines in rheumatic diseases. Curr Drug Targets. 2006;7(1):91-102.
16. Feldmann M, et al., Future prospects for anti-cytokine treatment. Ann Rheum Dis. 2000;59 Suppl 1:i119-i122.
17. Okamura H, et al., Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 1995;378(6552):88-91.
18. Micallef MJ, et al. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur J Immunol. 1996;26(7):1647-1651.
19. Wagner AD, Goronzy JJ, Weyand CM. Functional profile of tissue infiltrating and circulating CD68+cells in giant cell arteritis. Evidence for two components of the disease. J Clin Invest. 1994;94(3):1134-1140.
20. Ma-Krupa W, et al. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med. 2004;199(2):173-183.
21. Trinchier, G, Interleukin-12 and its role in the generation of TH1 cells. Immunol Today. 1993;14(7):335-338.
22. Trinchier, G. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigenspecific adaptive immunity. Annu Rev Immunol. 1995;13:251-276.